Sclerostin, encoded by the sclerostin domain-containing protein 1 (SOSTDC1) gene, was recently found to be negatively correlated with the aggressiveness of non-small cell lung cancer and gastric cancer as lower expression was observed in metastases compared to primary tumors [34,35]. The gene discussed is SOSTDC1; the disease is non-small cell lung carcinoma.